
Sign up to save your podcasts
Or
$GS announces Q4 2024 earnings with notable results: EPS of $11.95, beating estimates by $3.66, and revenue at $13.87B, marking a 22.54% increase Y/Y. Key financial health metrics show ROE of 14.6% and a strong $3.1 trillion in assets under supervision. Risks include regulatory uncertainties and market conditions.
$GS announces Q4 2024 earnings with notable results: EPS of $11.95, beating estimates by $3.66, and revenue at $13.87B, marking a 22.54% increase Y/Y. Key financial health metrics show ROE of 14.6% and a strong $3.1 trillion in assets under supervision. Risks include regulatory uncertainties and market conditions.